Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) recognizing Battey antigen-derived peptide–MHC class II complexes is a specialized immune receptor found on the surface of CD4+ T lymphocytes (Janeway et al., 2001). It specifically binds to peptides derived from Mycobacterium intracellulare (historically known as the Battey bacillus) when they are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (Wolinsky, 1979). This interaction is a critical step in the cellular immune response against nontuberculous mycobacterial (NTM) infections, leading to T-cell proliferation and the secretion of pro-inflammatory cytokines like IFN-gamma and TNF-alpha (Griffith et al., 2007). While not a traditional target for small-molecule drugs, these TCRs are significant in the development of diagnostic assays, such as the PPD-B skin test, and are studied for their cross-reactivity with Mycobacterium tuberculosis antigens (Edwards et al., 1969). Understanding this TCR specificity is vital for differentiating between various mycobacterial infections and for designing targeted immunotherapies or vaccines for NTM lung disease. The receptor's role in orchestrating the delayed-type hypersensitivity response makes it a key focus in mycobacterial immunology research.
The TCR recognizes and binds to the specific peptide-MHC II complex, initiating intracellular signaling via the CD3 complex, leading to T-cell activation, cytokine secretion, and orchestration of the cell-mediated immune response against Mycobacterium intracellulare.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Battey antigen-derived peptide–MHC class II complexes.